Open Access Policy

Open Access Policy

The Journal Draft – AI in Medicine is committed to the unrestricted dissemination of scientific knowledge. As a fully open-access journal, we ensure that all published articles are immediately and permanently accessible online without subscription fees or access barriers. Our open-access model supports global knowledge sharing and encourages wide readership among clinicians, researchers, educators, policymakers, and industry professionals.

1. Immediate and Free Access

All articles published in The Journal Draft are freely available online immediately upon publication. Readers do not require:

  • Subscription

  • Registration

  • Institutional login

  • Payment or paywall access

This ensures maximum visibility, accessibility, and impact of the research we publish.

2. Author Copyright Retention

Authors retain full copyright of their work. Upon publication, authors grant the journal a non-exclusive right to publish the accepted manuscript. This ensures:

  • Authors maintain ownership of their intellectual property

  • Authors may distribute, archive, or reuse their work at any time

  • The final published version can be shared publicly and legally

3. Creative Commons Licensing

To promote ethical use and global dissemination, all articles are published under a Creative Commons license selected by the journal or the author (e.g., CC BY, CC BY-NC).
You may choose one of the following licenses based on your policy preference:

Common CC Licensing Options:

  • CC BY (Attribution):
    Allows unrestricted sharing, adaptation, and commercial use, with proper attribution.
    Most widely used in scientific publishing.

  • CC BY-NC (Attribution-NonCommercial):
    Allows sharing and adaptation for non-commercial purposes, with attribution.

  • CC BY-ND (Attribution-NoDerivatives):
    Allows redistribution with attribution but prohibits modifications.

If you prefer, I can help you select the best license for your journal.

4. Reuse and Distribution Rights

Under the selected Creative Commons license, users are free to:

  • Read and download articles

  • Share content via any platform

  • Print, store, or distribute articles

  • Translate or adapt content (depending on license)

  • Use data or figures with proper citation

No additional permissions are required as long as the terms of the Creative Commons license are respected.

5. Archiving and Depositing Rights

Authors are permitted and encouraged to deposit any version of their article—preprint, accepted manuscript, or final published PDF—into:

  • Institutional repositories

  • Subject repositories (e.g., arXiv, PubMed Central*)

  • Author websites or lab pages

  • Research networking platforms (e.g., ResearchGate, Academia)**

*Eligibility depends on subject area.
**Always following copyright and CC license terms.

This supports long-term preservation and wider dissemination.

6. No Embargo Period

The journal does not impose embargoes. All content is accessible immediately upon publication, promoting:

  • Rapid knowledge transfer

  • High visibility for authors

  • Increased citation potential

7. Compliance With Open Access Mandates

Our open-access policy aligns with major international funder requirements, such as:

  • Plan S

  • Wellcome Trust

  • NIH Public Access Policy

  • European Commission Open Science mandates

  • Indian government and global health research funder guidelines

Authors can meet funding agencies’ open-access obligations easily by publishing with us.

8. Article Processing Charges (APC)

If you plan to charge APCs in the future, this section can be expanded.
For now, you can add:

Currently, The Journal Draft does not charge article processing fees (APCs). All publications in the Special Launch Issue and early volumes will be available at no cost to authors.

(This encourages submissions for a new journal.)

Summary

By adopting a transparent and inclusive open-access model, The Journal Draft ensures that all research related to AI in Medicine is widely accessible, reproducible, and beneficial to the global scientific community.